Concurrent twice-weekly paclitaxel and thoracic irradiation for stage III non-small cell lung cancer

Seminars in Radiation Oncology

Volumn 9, Issue 2 SUPPL. 1, 1999, Pages 117-120

  Lau, D ^a   Ryu, J ^a   Gandara, D ^a   Morgan, R ^a   Doroshow, J ^a   Wilder, R ^a   Leigh, B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; ESOPHAGITIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; RADIATION DOSE; SKIN EXFOLIATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; RADIATION-SENSITIZING AGENTS; SURVIVAL ANALYSIS;

EID: 0032932543     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)